loader from loading.io

Why you should care about the shakeup at NIH: Sean Morrison, Ken Covinsky, Stacy Fischer

GeriPal - A Geriatrics and Palliative Medicine Podcast

Release Date: 06/18/2026

Flu, COVID, RSV, & Shingles Vaccines in Older Adults: Ken Schmader and Sharon Brangman show art Flu, COVID, RSV, & Shingles Vaccines in Older Adults: Ken Schmader and Sharon Brangman

GeriPal - A Geriatrics and Palliative Medicine Podcast

Just in time for respiratory virus season, this episode of the podcast breaks down essential vaccine guidance for older adults. From flu, COVID-19, and RSV to an added bonus deep dive into shingles, we cover everything you need to know to protect older adults this season. Our expert guests include: Kenneth Schmader, MD: A geriatrician and vaccine researcher who helped develop the zoster vaccine. Ken serves on the Working Groups for the Herpes Zoster, Influenza, COVID-19, RSV and General Adult Immunization Guidelines for the US Centers for Disease Control (CDC) Advisory Committee on...

info_outline
Financial Mistakes and Exploitation in Dementia: Lauren Nicholas, Duke Han, Jason Karlawish show art Financial Mistakes and Exploitation in Dementia: Lauren Nicholas, Duke Han, Jason Karlawish

GeriPal - A Geriatrics and Palliative Medicine Podcast

Difficulty managing money is often one of the earliest signs of Alzheimer's disease and related dementias, frequently appearing years before an official diagnosis. This loss of financial capacity leaves individuals vulnerable to costly mistakes and exploitation, threatening the financial security and quality of life of entire families. In this episode, we sit down with Dr. Lauren Hersch Nicholas, Dr. Duke Han, and Dr. Jason Karlawish to examine the intersection of cognitive decline, financial decision-making, and patient protection. We covered a lot of topics, including these key ones: The...

info_outline
Weight loss, GLP-1s and Sarcopenia: A Podcast with John Batsis, Shen Dewar, Aruna Josyula show art Weight loss, GLP-1s and Sarcopenia: A Podcast with John Batsis, Shen Dewar, Aruna Josyula

GeriPal - A Geriatrics and Palliative Medicine Podcast

GLP-1 receptor agonists (the "Ozempics of the world") have been a truly revolutionary pharmacological advance in modern medicine. In randomized controlled trials (RCTs), these agents have been shown to do much more than just reduce weight, including significantly reducing cardiovascular events, lowering all-cause mortality in patients with type 2 diabetes, and even slowing the progression of chronic kidney disease. But as we see their use rapidly expand among older adults, we have to ask: at what cost? In geriatrics, weight loss is rarely simple. In older bodies, GLP1s carry increased risks,...

info_outline
Who Should Palliative Care See? Diane Meier, Bob Arnold, and Justin Sanders show art Who Should Palliative Care See? Diane Meier, Bob Arnold, and Justin Sanders

GeriPal - A Geriatrics and Palliative Medicine Podcast

As Diane Meier remarks to start today’s podcast, palliative care has come a long way from the days when we were the “brink of death” consult. We’re seeing patients earlier and earlier in the course of illness.  In fact, the for specialist palliative care is arguably stronger in the outpatient setting than the inpatient setting. In some ways, as Eric remarked, we are a victim of our own success. We’ve pushed on the boundaries of seeing patients earlier in the course of illness, we’ve demonstrated remarkable value to our colleagues and health systems: now they want us to see...

info_outline
LATE vs Alzheimer’s: Biomarkers, Mixed Dementia, and Clinical Realities with Nate Chin & Sterling Johnson show art LATE vs Alzheimer’s: Biomarkers, Mixed Dementia, and Clinical Realities with Nate Chin & Sterling Johnson

GeriPal - A Geriatrics and Palliative Medicine Podcast

Up until just a couple years ago, an 85-year-old patient presenting with gradual, amnestic memory loss was almost automatically presumed to have Alzheimer’s disease. However, new biomakers and the recognition of conditions like Limbic-predominant age-related TDP-43 encephalopathy (LATE) are reshaping our understanding of cognitive decline in older adults. It’s looking more clear that pure Alzheimers dementia is rare in older adults, and co-occurring pathologies that may include Alzheimer's, LATE, Lewy Body, and vascular neuropatholigies, are the rule rather than the exception.  In...

info_outline
Video-Enhanced Advance Care Planning: Joshua Lakin and Kei Ouchi show art Video-Enhanced Advance Care Planning: Joshua Lakin and Kei Ouchi

GeriPal - A Geriatrics and Palliative Medicine Podcast

Can simple, evidence-based video decision aids—paired with structured clinician training—improve Advance Care Planning (ACP) documentation and goal-concordant care? That’s the question we pose in this week's podcast with Dr. Joshua Lakin and Dr. Kei Ouchi. We break down the methodologies behind two major clinical trials in which they were involved that implemented this video-enhanced approach. The f was a multicenter, parallel randomized trial of 598 seriously ill older adults in emergency departments (EDs). It tested whether watching a 5-minute video and having a short, 10-minute...

info_outline
Longevity Treatments - Snake Oil or Breakthrough? John Newman & Mahtab Jafari show art Longevity Treatments - Snake Oil or Breakthrough? John Newman & Mahtab Jafari

GeriPal - A Geriatrics and Palliative Medicine Podcast

The longevity industry is booming. Influencers are promoting this and that as promoting healthy aging, longevity, and healthspan, and it’s hard for us, much less our patients, to make sense of it.  To be sure, we should always start by recommending exercise, nutritious foods, good sleep habits, and meaningful social interaction.  We wanted to go beyond that to talk about the promise and potential and risks/harms of “biohacks.” Today we talk with Mahtab Jafari, PharmD, and John Newman, MD, PhD, and to discuss: How we clinicians should think about this movement, knowing many of...

info_outline
Who Should Deliver Palliative Care in Liver Disease? Chris Woodrell, Manisha Verma, Marie Bakitas show art Who Should Deliver Palliative Care in Liver Disease? Chris Woodrell, Manisha Verma, Marie Bakitas

GeriPal - A Geriatrics and Palliative Medicine Podcast

Who's better at delivering palliative care to patients with liver disease: palliative care specialists, or hepatologists who have received liver disease-specific palliative care training?  That’s the question we take a deep dive into on this week's podcast by breaking down the We’ve invited three of the trial's authors, , , and , to discuss this cluster-randomized clinical trial spanning 19 U.S. medical centers. We’ll discuss: Why was this trial done? Do we really need to run a separate palliative care trial for every single organ disease? What kind of specialized palliative...

info_outline
Why you should care about the shakeup at NIH: Sean Morrison, Ken Covinsky, Stacy Fischer show art Why you should care about the shakeup at NIH: Sean Morrison, Ken Covinsky, Stacy Fischer

GeriPal - A Geriatrics and Palliative Medicine Podcast

Emergency Podcast! Our guests Sean Morrison, Ken Covinsky, and Stacy Fischer believe that you should care deeply about the proposed shakeup at the National Institutes of Health.  Major at the would affect a huge range of government grants, from Headstart to Transportation to the National Science Foundation, as well as the National Institutes of Health (NIH), the subject of today’s podcast. You dear listeners should all care.  You should care because you care for older adults, or you’re a researcher who studies palliative care, or you're a chaplain who visited with the family of...

info_outline
How We Limit Non-beneficial Life Sustaining Treatments: Jason Batten, Liz Dzeng, Teva Brender show art How We Limit Non-beneficial Life Sustaining Treatments: Jason Batten, Liz Dzeng, Teva Brender

GeriPal - A Geriatrics and Palliative Medicine Podcast

Today’s podcast is a natural follow up to our podcasts on and .Today we talk about a new study about how clinicians , published in JAMA Network Open. Do they adhere to society guidelines, which allow as permissible approaches only shared decision-making and following institutional policy.  Or do they take alternative approaches, like not offering interventions, not mentioning interventions, or simply stating a plan to limit interventions? Turns out doctors are using these alternative approaches frequently. Our guests are Jason Batten, Liz Dzeng, and Teva Brender, all clinicians, all of...

info_outline
 
More Episodes

Emergency Podcast! Our guests Sean Morrison, Ken Covinsky, and Stacy Fischer believe that you should care deeply about the proposed shakeup at the National Institutes of Health.  Major proposed rules changes at the Office of Management and Budget, would affect a huge range of government grants, from Headstart to Transportation to the National Science Foundation, as well as the National Institutes of Health (NIH), the subject of today’s podcast.

You dear listeners should all care.  You should care because you care for older adults, or you’re a researcher who studies palliative care, or you're a chaplain who visited with the family of a patient who died today.  You should care because these rule changes are so sweeping that they would remove standard components of the scientific review process and instead put them in the hands of political appointees.

You should care because if rules like this were in place in the 1980s, we might not have developed treatments to stop the HIV/AIDS epidemic.  You should care because if these rules go into effect we will not be able to work with researchers in other countries studying outbreaks of Ebola or Hauntavirus.  You should care because these rules silence federal research into groups of people we care for daily.

And if you’re not a researcher, your voice is even more important here.  As Sean says, researchers who protest these proposed rule changes might come across as self-serving.  Clinicians who are not researchers -  who can say that these rules will negatively impact the science that improves care of older adults living with chronic conditions and their families - your voices may resonate even more.

What can you do? Most of these rule changes are open for public comment here until July 13, 2026.  Every comment will be read and requires a response.  It’s ok to respond anonymously.  Personalized stories matter more than form responses. Tips:

  1. 1: Say (or just describe to keep anonymous) who you are and why you are qualified to comment. Telling the story of how patients and families you care for or study is enough.  Get your partner and parents to respond too.  Simply being a concerned citizen is perfectly fine.

  2. 2: List the exact provision #s that concern you, and explain what they would do. You do not need to quote the rule directly. Just explain what you understand it to mean in plain terms.

    1. Political Appointees Take Control of Grant Awards (§200.205);

    2. Peer Review Is No Longer Binding (§200.205(d));

    3. Active Grants Can Be Terminated at Any Time, for Any Reason (§200.340); 

    4. DEI, Gender Research, and Related Topics Banned as Grant Conditions (§200.300); 

    5. Prohibition on International Scientific Collaboration (§200.220); 

    6. Conference Attendance Now Requires Express Agency Pre-Approval (§200.432); 

    7. Publication Costs and Open Access Fees Presumptively Unallowable (§200.461)

  3. 3: Explain the concrete harm. What would happen to your patients and their families if this provision takes effect?

  4. 4: Closing: State clearly what you want OMB to do. This can be as simple as: “I urge OMB to withdraw these specific provisions: §200.340, §200.202, §200.205.” or “I urge OMB not to finalize this rule.”

Submit your comment in opposition here: The deadline is July 13, 2026.  You can also email your congressperson or senator.  

Times they are a changin’.